Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2017
Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decadesA Nordin, F Åberg, E Pukkala, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitisM J Nielsen, D Thorburn, D J Leeming, et al.
Hepatology (Baltimore, Md.)|August 26, 2021
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bileHege Marie Vedeld, Marit M Grimsrud, Kim Andresen, et al.
Genes and Immunity|April 24, 2009
Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseasesX Yu, S Wieczorek, A Franke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 13, 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct diseaseSigrid Naess, Einar Björnsson, Jarl A Anmarkrud, et al.
Clinical and Experimental Immunology|February 12, 2016
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinomaF Bernuzzi, F Marabita, A Lleo, et al.
Annals of the Rheumatic Diseases|December 11, 2007
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseasesM C Eike, G B N Nordang, T H Karlsen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2016
No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing CholangitisRoman Zenouzi, Tobias J Weismüller, Kristin K Jørgensen, et al.
Gastroenterology|November 16, 2005
High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled studyRolf Olsson, Kirsten M Boberg, Ove Schaffalitsky de Muckadell, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2026
Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis by DNA methylation biomarkers in bile and plasmaHege Marie Vedeld, Sigurd Breder, Heidi Pharo, et al.
Pageof 12